AndreaBozzo/ceres-open-data-index huggingface dataset:
Organization specific predictors of job satisfaction: findings from a Canadian multi-site quality of work life cross-sectional survey

Background
          Organizational features can affect how staff view their quality of work life. Determining staff perceptions about quality of work life is an important consideration for employers interested in improving employee job satisfaction. The purpose of this study was to identify organization specific predictors of job satisfaction within a health care system that consisted of six independent health care organizations.
        
        
          Methods
          5,486 full, part and causal time (non-physician) staff on active payroll within six organizations (2 community hospitals, 1 community hospital/long-term care facility, 1 long-term care facility, 1 tertiary care/community health centre, and 1 visiting nursing agency) located in five communities in Central West Ontario, Canada were asked to complete a 65-item quality of work life survey. The self-administered questionnaires collected staff perceptions of: co-worker and supervisor support; teamwork and communication; job demands and decision authority; organization characteristics; patient/resident care; compensation and benefits; staff training and development; and impressions of the organization. Socio-demographic data were also collected.
        
        
          Results
          Depending on the organization, between 15 and 30 (of the 40 potential predictor) variables were found to be statistically associated with job satisfaction (univariate analyses). Logistic regression analyses identified the best predictors of job satisfaction and these are presented for each of the six organizations and for all organizations combined.
        
        
          Conclusions
          The findings indicate that job satisfaction is a multidimensional construct and although there appear to be some commonalities across organizations, some predictors of job satisfaction appear to be organization and context specific.
Patent AT-E400371-T1: [Translated] MOLECULES OF CERTAIN ACTIVITY RECEIVING SUPPORT AND METHOD FOR ENSURE THE PRESENCE OF SUCH MOLECULES ON SUCH SUPPORT

Support (1) for active molecules (2, 2') whose activity is against undesirable organisms or phenomena or in favor of a desired phenomenon comprises means (3) for trapping at least part of the active molecules while maintaining their activity.  Independent claims are also included for:  (1) ensuring the presence of active molecules in a support as above, comprising preparing a composition comprising the active molecules and a polymerizable and/or crosslinkable substance (6) capable of forming a network with at least one amorphous zone (7), ensuring the presence of the composition on the support, and trapping active molecules in the amorphous zone(s);  (2) a composition as above.
Genetic markers of osteoarticular disorders: facts and hopes

Osteoarthritis and osteoporosis are the two most common age-related chronic disorders of articular joints and skeleton, representing a major public health problem in most developed countries. Apart from being influenced by environmental factors, both disorders have a strong genetic component, and there is now considerable evidence from large population studies that these two disorders are inversely related. Thus, an accurate analysis of the genetic component of one of these two multifactorial diseases may provide data of interest for the other. However, the existence of confounding factors must always be borne in mind in interpreting the genetic analysis. In addition, each patient must be given an accurate clinical evaluation, including family history, history of drug treatments, lifestyle, and environment, in order to reduce the background bias. Here, we review the impact of recent work in molecular genetics suggesting that powerful molecular biology techniques will soon make possible both a rapid accumulation of data on the genetics of both disorders and the development of novel diagnostic, prognostic, and therapeutic approaches.
Patent AT-E400514-T1: [Translated] INSULATED CONTAINER AND METHOD FOR PRODUCING SAME

The invention relates to a method of fabricating an insulating container (10) for hot drinks or the like. The container includes an inner cup (12) having a generally frusto-conical cup body (22), a generally frusto-conical outer shell (14), a thermo-sealable plastic coating (42) on at least one of the inside of said shell and the outside of said cup body. The cup is seated within said shell so that the coating extends at least along a contact path (3) near the upper edge (9) of the shell along which contact path outer surface of the cup body and inner surface of the shell are in contact and are bonded.
Long-term outcome after coronary stenting

The present review assesses the data on long-term outcome after coronary stenting. Histological, angiographical and intravascular imaging data have shown that the insertion of stents constitutes only a transient stimulus to lumen renarrowing, that this process is almost complete at 6 months and that a certain degree of neointima regression is also possible after this time. Clinical data have confirmed the sustained benefit of stenting in the long term. Careful selection of optimal stent designs and application of the recent advances in adjunctive pharmacological therapy are currently effective strategies to improve both short-and long-term results with coronary stenting. However, further efforts are needed and are ongoing to combat restenosis, a process that counters the excellent short-term results of stenting in the long term.
Patent AT-E401842-T1: [Translated] AUDITORIAL ossicle prosthesis

The bars (13) of the ball joint exhibits a long hole form recess in longitudinal direction. The balls are arranged equidistantly to length of the axle of the shank. The shank contains flexible bar suspended through-holes of the balls. The balls are produced by lasers and welded by laser welding. The plate, bell, stamp or tie-clip shaped fastening elements (11, 12) contains a head plate formed at drum skin. The prosthesis is by opening of the human ear shell directly coupled to interior of ear. The prosthesis is: arranged to terminator point of the hammer, to anvil extension, to the stirrup or directly dipped into interior ear; connected with an implantable hearing aid; and marked as a function of frequency response of the sound line in the tympanic cavity. The prosthesis parts are produced from silicone or glass reinforced thermosetting plastics, titanium, gold, tantalum and/or alloys or nitinol.
Denver: Drug-Related Emergency Department Visits, 2004-2011 - All Visits

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits in the Denver metropolitan area, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved. It includes visits involving all forms of drug misuse or abuse plus visits resulting from adverse reaction, accidental ingestion, suicide attempts, and visits where patients were seeking detoxification services. These estimates are useful for looking at overall levels of drug involvement in ED visits.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 526382: 1,3,7-Tribromodibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1,3,7-tribromodibenzo-p-dioxin. Molecular Formula: C12H5Br3O2. Molecular Weight: 420.88. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Calcium-mediated transductive systems and functionally active gap junctions in astrocyte-like GL15 cells

Background
          It has been proposed that GL15, a human cell line derived from glioblastoma multiforme, is a possible astroglial-like cell model, based on the presence of cytoplasmic glial fibrillary acidic protein.
        
        
          Results
          The aim of this work was to delineate the functional characteristics of GL15 cells using various experimental approaches, including the study of morphology, mechanism of induction of intracellular Ca2+ increase by different physiological agonists, and the presence and permeability of the gap-junction system during cell differentiation.
          Immunostaining experiments showed the presence and localization of specific glial markers, such as glial fibrillary acidic protein and S100B, and the lack of the neuronal marker S100A. Notably, all the Ca2+ pathways present in astrocytes were detected in GL15 cells. In particular, oscillations in intracellular Ca2+ levels were recorded either spontaneously, or in the presence of ATP or glutamate (but not KCl).
          Immunolabelling assays and confocal microscopy, substantiated by Western blot analyses, revealed the presence of connexin43, a subunit of astrocyte gap-junction channels. The protein is organised in characteristic spots on the plasma membrane at cell-cell contact regions, and its presence and distribution depends on the differentiative status of the cell. Finally, a microinjection/dye-transfer assay, employed to determine gap-junction functionality, clearly demonstrated that the cells were functionally coupled, albeit to varying degrees, in differentiated and undifferentiated phenotypes.
        
        
          Conclusions
          In conclusion, results from this study support the use of the GL15 cell line as a suitable in vitro astrocyte model, which provides a valuable guide for studying glial physiological features at various differentiation phases.
Title IV-E Foster Care Eligibility Reviews 2020 Schedule

Postponement of the Title IV-E Foster Care Eligibility Reviews

The Children's Bureau has indefinitely postponed the Title IV-E Foster Care Eligibility Reviews due to the COVID-19 pandemic. Following the PDF link to the schedule below is a link to a letter announcing the postponement sent on April 10, 2020, from Associate Commissioner Jerry Milner to child welfare leaders.

Letter from Associate Commissioner Jerry Milner

Browse All COVID-19 Resources

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 528133: 3-Methyl-5-(2-methylpentyl)-2-(methylthio)pyrazine

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-5-(2-methylpentyl)-2-methylsulfanylpyrazine. Molecular Formula: C12H20N2S. Molecular Weight: 224.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399529-T1: [Translated] GALENIC FORMULATION

Cosmetic or dermatological formulations which comprise one or more active ingredients selected from phylloquinone, 2-hydroxy-5-methyllaurophenone oxime, vitamin A and its derivatives, vitamin E and its derivatives, vitamin H, allantoin, bisabolol, nicotinic acid derivatives and caffeine and in addition (a) one or more antioxidants and/or (b) one or more UV filters, are distinguished, in particular, by the fact that the active ingredients present in the formulation according to the invention are stabilised.
Homing chemokines in rheumatoid arthritis

In about 20% of patients with rheumatoid arthritis, B and T lymphocytes recruited into the inflamed synovium are organized into complex microstructures, which resemble secondary lymphoid organs. The development of such lymphoid aggregates with germinal centers appears to contribute to the pathogenesis of the disease. Growing evidence indicates that chemokines and their receptors control the recruitment and positioning of leukocytes as well as their organization into node-like lymphoid structures. Here, we comment on recent studies highlighting the importance of chemokines in rheumatoid arthritis, in particular of B-cell-activating chemokine-1 in lymphoid neogenesis in the inflamed synovium.
National Hospital Care Survey (NHCS) linked to Department of Housing and Urban Development (HUD) Administrative Housing Data

Through its data linkage program, NCHS has been able to expand the analytic utility of the data collected from the 2014 and 2016 National Hospital Care Surveys (NHCS) by linking patient records with up to three years of administrative housing data from the U.S. Department of Housing and Urban Development’s (HUD) largest housing assistance programs: the Housing Choice Voucher (HCV) program, Public Housing (PH) , and privately owned, subsidized Multifamily housing (MF). These innovative linked data will support a wide array of patient outcomes studies, including the opportunity to study complex relationships between housing and health.
NNDSS - TABLE 1I. Cryptosporidiosis to Cyclosporiasis

NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 526552: 1,3-Dioxolane, 2-(2-methylpropyl)-

Chemical compound data from PubChem database. IUPAC Name: 2-(2-methylpropyl)-1,3-dioxolane. Molecular Formula: C7H14O2. Molecular Weight: 130.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Title IV-E Foster Care Eligibility Reviews and Monitoring of Certain Provisions regarding the Family First Prevention Services Act

This Program Instruction (PI) disseminates the revised Title IV-E Foster Care Eligibility Review Guide, reflecting changes in title IV-E eligibility requirements enacted through the Family First Prevention Services Act of 2018 (the Family First Act).

PI-23-06 (PDF)

Title IV-E Foster Care Eligibility Review Guide

Planned Schedule of IV-E Reviews by Fiscal Year

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525085: 3beta-(Trimethylsiloxy)androst-5-ene

Chemical compound data from PubChem database. IUPAC Name: (10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy-trimethylsilane. Molecular Formula: C22H38OSi. Molecular Weight: 346.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529785: Acetic acid, chloro, 3,5-bis-(trifluoromethyl)phenylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: [3,5-bis(trifluoromethyl)phenyl]methyl 2-chloroacetate. Molecular Formula: C11H7ClF6O2. Molecular Weight: 320.61. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Technical Bulletin #21 — XML File Structure and Encryption

This technical bulletin provides agencies with information required to create the AFCARS data files.  It provides technical specifications on the structural layout of the XML data and shares the XML schema for the Out-of-Home Care File and the Adoption and Guardianship Assistance File.  It also covers information on encryption of the file records. This Technical Bulletin was last revised on October 10, 2023.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527714: 4,6-Dichlorodibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 4,6-dichlorodibenzofuran. Molecular Formula: C12H6Cl2O. Molecular Weight: 237.08. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014 NSDUH MRB Sample Experience Report

A coordinated sample design was developed for the 2014 through 2017 National Surveys on Drug Use and Health (NSDUHs).  The multiyear design consists of a deeply stratified, multistage area probability design. The 2014 sample design is thoroughly documented in the 2014 NSDUH sample design report (Center for Behavioral Health Statistics and Quality, 2015a). The goal of this report is to further document the 2014 NSDUH sample experiences, including a comparison of actual sample yields to state and quarter targets, a comparison of achieved and expected design effects (DEFFs) and relative standard errors (RSEs), and documentation of any issues encountered during sample implementation. In addition, any unforeseen issues related to the 2014 sample redesign will be documented.
Compound 525598: N,N-Dimethyl-N'-(4-methoxyphenyl)-benzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-methoxyphenyl)-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C16H18N2O. Molecular Weight: 254.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2011 CMHS Uniform Reporting System (URS) Output Tables for Maryland

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
High-tech and low-tech orthopaedic surgery in Sub-Saharan Africa

Background
          Zambia's governmental health system suffers from shortage of surgical supplies and poor management skills for the sparse resources at hand. The situation has been worsened by the dual epidemics of HIV disease and tuberculosis. On the other hand the private medical sector has benefited greatly from less bureaucracy under the goverment of the Movement for Multi-party Democracy.
        
        
          Discussion
          The Zambian-Italian Orthopaedic Hospital in Lusaka is a well organized small unit providing free treatment of physically disabled children. The running costs are met from the fees charged for private consultations, supplemented by donations. State of the art surgical techniques are being used for congenital and acquired musculo-skeletal abnormalities. Last year 513 patients were operated upon free of charge and 320 operations were performed on private patients.
Compound 526043: Silane, [[(17beta)-estra-1,3,5(10)-triene-2,3,17-triyl]tris(oxy)]tris*trimethyl-

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[[13-methyl-2,3-bis(trimethylsilyloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxy]silane. Molecular Formula: C27H48O3Si3. Molecular Weight: 504.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526726: Triethylene glycol, decyl ether, TMS

Chemical compound data from PubChem database. IUPAC Name: 2-[2-(2-decoxyethoxy)ethoxy]ethoxy-trimethylsilane. Molecular Formula: C19H42O4Si. Molecular Weight: 362.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
AFCARS Out-of-Home Care and Adoption and Guardianship Assistance Data Elements List with Definitions

This is a list of the Out-of-Home Care and Adoption and Guardianship Assistance data elements with their definitions as published in the AFCARS final rule issued on December 14, 2016 (81 FR 90524
  
  

)

Metadata-only record linking to the original dataset. Open original dataset below.
Benefits and Cost Sharing PUF - PY2017

The Benefits and Cost Sharing PUF (BenCS-PUF) is one of the files that make up the Marketplace PUF. The BenCS-PUF contains plan-level data on essential health benefits, coverage limits, and cost sharing for each QHP and SADP. These data either originate from the Plans &amp; Benefits template (i.e., template field), an Excel-based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).
Compound 527108: 1,2-Dihydroperillaldehyde

Chemical compound data from PubChem database. IUPAC Name: 4-prop-1-en-2-ylcyclohexane-1-carbaldehyde. Molecular Formula: C10H16O. Molecular Weight: 152.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530634: Valeric acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2,6-dimethylnon-1-en-3-yn-5-yl pentanoate. Molecular Formula: C16H26O2. Molecular Weight: 250.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.